Analysis of Human Sodium Iodide Symporter Gene Expression in Extrathyroidal Tissues and Cloning of Its Complementary Deoxyribonucleic Acids from Salivary Gland, Mammary Gland, and Gastric Mucosa

Abstract

The ability to concentrate iodide is a fundamental property of normally functioning thyroid tissue and represents the first step in the production of thyroid hormones. Iodide uptake has been demonstrated in various extrathyroidal tissues, including salivary gland, gastric mucosa, and lactating mammary gland. Recently, cloning and molecular characterization of the human sodium iodide symporter (hNIS) have been reported; however, the patterns of hNIS gene expression in human tissues have remained unidentified. To examine the profiles of human hNIS gene expression in various normal human tissues, we performed high-stringency Northern blot analysis using a 32 P-labeled hNIS-specific complementary DNA (cDNA) probe (nucleotides 1184 -1667). To detect rare hNIS transcripts in small tissue samples, RT-PCR was performed with a pair of hNIS-specific oligonucleotide primers designed to amplify a portion (nucleotides 1184 -1667) of the hNIS gene. hNIS-specific transcripts were confirmed by Southern hybridization using a digoxigenin-labeled internal hNISspecific oligonucleotide probe (nucleotides 1460 -1477). To monitor cDNA integrity and quantity, and to rule out DNA contamination and illegitimate transcription, all samples were coamplified with two pairs of intron-spanning primers designed to amplify fragments of the human ␤-actin and thyroglobulin genes, respectively. Using Northern blot analysis, hNIS transcripts of approximately 4 kb were detected in thyroid gland and parotid gland but not in a broad range of endocrine and nonendocrine tissues. RT-PCR and Southern hybridization revealed hNIS gene expression in thyroid gland, salivary gland, parotid gland, submandibular gland, pituitary gland, pancreas, testis, mammary gland, gastric mucosa, prostate and ovary, adrenal gland, heart, thymus, and lung. By contrast, hNIS transcripts were not detected in normal orbital fibroblasts, colon, and nasopharyngeal mucosa. To further analyze hNIS gene sequences in parotid gland, mammary gland, and gastric mucosa, the EXPAND High Fidelity PCR System and three sets of overlapping NIS oligonucleotide primers were used for amplification and cloning. The resulting PCR products were subcloned into pBluescript-SK II (Ϫ) vector, and at least two independent cDNA clones derived from each tissue were subjected to automated sequencing. The nucleotide sequences of hNIS cDNA derived from parotid gland, mammary gland, and gastric mucosa revealed full identity with the recently published human thyroidderived NIS cDNA sequence. In conclusion, our results demonstrate markedly variable levels of hNIS gene expression in several extrathyroidal tissues. Although the physiological role of hNIS in these tissues awaits further study, our results suggest that the capacity to actively transport iodine may be a feature common to several secretory and endocrine tissues. The diminished capacity to transport and concentrate iodide in extrathyroidal tissues (such as parotid gland, mammary gland, and gastric mucosa), compared with thyroid gland, does not s...

Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer

“…Spitzweg et al (32) reported that breast cancer and thyroid tissue express sodium iodide symporter genes; and Kilbane et al (33) demonstrated that breast cancer tissue iodine content was significantly lower compared to that in normal breast tissue or fibroadenoma, suggesting an iodine uptake pathology in breast cancer. Previous epidemiological studies demonstrated an inverse correlation between iodine intake and breast cancer incidence (12,34).…”

Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models

“…5,6 Endogenous expression of the hNIS gene has been found primarily in thyroid tissue but also, to a much lower extent, in other secretory and exocrine tissues. 7 These observations indicate that, following thyroid blockade, it may be possible to deliver Na 131 I to transfected, hNIS-expressing, tumor cells with minimal uptake of radioactivity in normal tissues.…”

Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non–small cell lung cancer

“…8 Endogenous NIS expression has not been found in lung cancer and it is not present in normal lung tissue. 9,13 Transfection of a variety of tumors including melanoma, colon carcinoma, ovarian adenocarcinoma, lung cancer, 10,11 and prostate cancer 12 with an NIS -expressing vector results in increased radioiodide uptake. However, rapid radioiodide efflux from these transfected cells may limit the antitumor efficacy of this therapeutic strategy.…”